Hypoxia-induced factor-1 alpha upregulates vascular endothelial growth factor C to promote lymphangiogenesis and angiogenesis in breast cancer patients
Authors:
Open Access
- 1 January 2013
- journal article
- Published by Journal of Biomedical Research in Journal of Biomedical Research
- Vol. 27 (6) , 478-85
Abstract
Hypoxia-induced factor-1 alpha (HIF-1α) affects many effector molecules and regulates tumor lymphangiogenesis and angiogenesis during hypoxia. The aim of this study was to investigate the role of HIF-1α in the regulation of vascular endothelial growth factor C (VEGF-C) expression and its effect on lymphangiogenesis and angiogenesis in breast cancer. Lymphatic vessel density (LVD), microvessel density (MVD) and the expressions of HIF-1α and VEGF-C proteins were evaluated by immunohistochemistry in 75 breast cancer samples. There was a significant correlation between HIF-1α and VEGF-C (P = 0.014, r = 0.273, Spearman's coefficient of correlation). HIF-1α and VEGF-C overexpression was significantly correlated with higher LVD (P = 0.003 and P = 0.017, respectively), regional lymph nodal involvement (P = 0.002 and P = 0.004, respectively) and advanced tumor, node, metastasis (TNM) classification (P = 0.001 and P = 0.01, respectively). Higher MVD was observed in the group expressing higher levels of HIF-1α and VEGF-C (P = 0.033 and P = 0.037, respectively). Univariate analysis showed shorter survival time in patients expressing higher levels of HIF-1α and VEGF-C. HIF-1α was also found to be an independent prognostic factor of overall survival in multivariate analysis. The results suggest that HIF-1α may affect VEGF-C expression, thus acting as a crucial regulator of lymphangiogenesis and angiogenesis in breast cancer. This study highlights promising potential of HIF-1α as a therapeutic target against tumor lymph node metastasis.Keywords
This publication has 30 references indexed in Scilit:
- Lymphangiogenesis and lymphatic metastasis in breast cancerPathophysiology, 2010
- The relationship between proangiogenic gene expression levels in prostate cancer and their prognostic value for clinical outcomesThe Prostate, 2010
- Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeuticsOncogene, 2009
- Hypoxia inducible factor-1α correlates with vascular endothelial growth factor A and C indicating worse prognosis in clear cell renal cell carcinomaJournal of Experimental & Clinical Cancer Research, 2009
- Expression of hypoxia-inducible factor-1 alpha and its prognostic significance in small-sized adenocarcinomas of the lungEuropean Journal of Cardio-Thoracic Surgery, 2006
- Hypoxia inducible factor-1α correlates with VEGF-C expression and lymphangiogenesis in breast cancerBreast Cancer Research and Treatment, 2006
- Expression of vascular endothelial growth factor (VEGF)-C and -D in gastric carcinomaInternational Journal of Clinical Oncology, 2006
- Inhibition of Lymphogenous Metastasis Using Adeno-Associated Virus-Mediated Gene Transfer of a Soluble VEGFR-3 Decoy ReceptorCancer Research, 2005
- Lymphatics at the crossroads of angiogenesis and lymphangiogenesisJournal of Anatomy, 2004
- Expression of hypoxia‐inducible factor‐1α is associated with tumor vascularization in human colorectal carcinomaInternational Journal of Cancer, 2003